Mark Bryan Mitchell

Title: Mark Bryan Mitchell: Innovator in Pharmaceutical Chemistry

Introduction

Mark Bryan Mitchell is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that focus on innovative compounds and their applications in treating various diseases.

Latest Patents

Mitchell's latest patents include the development of polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one. This invention relates to novel forms that may serve as components in pharmaceutical compositions aimed at treating conditions mediated by poly(ADP-ribose) polymerase activity, including cancer. Another significant patent involves methods for preparing indazole compounds, which are useful as modulators and/or inhibitors of protein kinases. This invention also details intermediate compounds that facilitate the preparation of these valuable compounds.

Career Highlights

Throughout his career, Mark Bryan Mitchell has worked with prominent companies such as Agouron Pharmaceuticals, Inc. and Cancer Research Technology Limited. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Mitchell has collaborated with talented individuals in his field, including Brigitte Leigh Ewanicki and Erik Jon Flahive. These partnerships have fostered innovation and enhanced the research outcomes in pharmaceutical chemistry.

Conclusion

Mark Bryan Mitchell's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to impact the development of treatments for serious health conditions.